BRIEF-Ipsen Biopharmaceuticals Canada Says Health Canada Approved Somatuline Autogel For Treatment Of Carcinoid Syndrome
February 13, 2018 at 07:42 AM EST
* IPSEN BIOPHARMACEUTICALS CANADA SAYS HEALTH CANADA APPROVES SOMATULINE AUTOGEL (LANREOTIDE INJECTION) 120 MG FOR TREATMENT OF CARCINOID SYNDROME Source text for Eikon: Further company coverage:
